Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial
Public ClinicalTrials.gov record NCT03699124. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Multicenter Phase III Trial to Evaluate Immunogenicity and Safety of Three Consecutive Production Lots of a Freeze-dried Formulation of MVA-BN® Smallpox Vaccine in Healthy, Vaccinia-naïve Subjects
Study identification
- NCT ID
- NCT03699124
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bavarian Nordic
- Industry
- Enrollment
- 1,129 participants
Conditions and interventions
Conditions
Interventions
- FD MVA-BN Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 45 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2019
- Primary completion
- Jan 5, 2020
- Completion
- Jun 21, 2020
- Last update posted
- May 26, 2021
2019 – 2020
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Optimal Research, LLC (Synexus) | Melbourne | Florida | 32934 | — |
| Optimal Research, LLC (Synexus) | Peoria | Illinois | 61614 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Kentucky Healthcare Chandler Hospital | Lexington | Kentucky | 40536 | — |
| Optimal Research, LLC (Synexus) | Rockville | Maryland | 20850 | — |
| Saint Louis University | St Louis | Missouri | 63104 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Rochester Clinical Research, Inc. | Rochester | New York | 14609 | — |
| M3 Wake Research, Inc. | Raleigh | North Carolina | 27612 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Omega Medical Research | Warwick | Rhode Island | 02886 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03699124, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 26, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03699124 live on ClinicalTrials.gov.